You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, March 19, 2021 /PRNewswire/ -- The "The Netherlands Diabetes Market, by Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast" report has been added to ResearchAndMarkets.com's offering. Netherlands Diabetes Market is gardened to reach USD 4.48 Billion by the year 2025. The Netherlands has observed a rise in the prevalence of type 2 diabetes during the last decade. As the Dutch population is aging and the incidence of obesity is a significant risk factor for diabetes is increasing, survival is improving, and multiple screening initiatives are implemented in the Netherlands. In 2013, nearly half the Dutch population suffered from at least one chronic disorder. One of the disorders with a high disease burden and reduction in quality of life is diabetes mellitus. In the Netherlands, the prevalence of diabetes mellitus (DM) is increasing rapidly. Netherlands care for diabetes is mainly concentrated in primary health care, with responsibility for most aspects of care in the hands of general practitioners. In general, primary health care in The Netherlands provides a good standard of care for subjects with DM. Another point of concern is the rise in the prevalence of obesity, leading to a vast increase in subjects with metabolic syndrome. DM (diabetes mellitus) care and its provision will continue to play an important role in health care in The Netherlands.The market of Continuous Glucose Monitoring (CGM) Device, Self Monitoring Blood Glucose Device, Insulin Pen, and Insulin Pump are growing due to the rising awareness for diabetes in Netherland. Diabetes care in The Netherlands has reached a high level of quality, but there is still an opportunity for further improvement. Not only is it a medical challenge but at least as much a burden for the Dutch economy and society. To fight with these risk factors, the Netherlands rolled out national health programs. In 2018, The National Prevention Agreement which was approved and sets out ambitious goals to make the Netherlands healthier by 2040, but it was in March 2019 that they are still far from reach.Over the past decade, the National Action program Diabetes (NAD) was implemented in the Netherlands. It is aimed to introduce the Care Standard (CS) for diabetes using a specific implementation plan and to pilot in several regions. In the year December 2019, Roche received CE Mark for its Accu-Chek SugarView app. Accu-Chek SugarView is the first app that checks the blood glucose ranges by taking pictures with the Smartphone camera without the requirement for a blood glucose meter.Key Topics Covered: 1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Driver4.1.1 Rising Diabetes Mellitus in an Aging Population4.1.2 Rising prevalence of diabetes in various age groups4.1.3 Benefits of Insulin Pump over Multiple Daily Injection4.1.4 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices4.2 Challenges4.2.1 Technological advancements in insulin infusion devices4.2.2 Blood Glucose Meter Accuracy Problem4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies4.2.4 Safety Issues in Insulin Pump Devices4.2.5 Difficulties Associated with the Pump4.2.6 Adherence5. Netherlands Diabetes Market6. Netherlands Diabetes Population6.1 Netherlands Diabetes Population & Forecast6.2 Type 1 & Type 2 Diabetes Population and Forecast7. Market Share Analysis - Netherlands Diabetic7.1 By Types8. Continuous Glucose Monitoring Market (CGM) - Netherlands Market & Users8.1 Netherlands - CGM Market by Components8.1.1 Glucose Sensor Market & Forecast8.1.2 CGM Transmitter Market & Forecast8.2 Netherlands - CGM User (2011 - 2025)8.3 CGM Reimbursement in the Netherlands9. Blood Glucose Device (SMBG) - United Kingdom Market & Users9.1 Market9.1.1 Type 1 & Type 2 (Diabetes)9.2 Test Strips Market and Forecast9.2.1 Type 1 & Type 2 (Diabetes)9.3 Lancet Market and Forecast9.3.1 Type 1 & Type 2 (Diabetes)9.4 Meter Market and Forecast9.4.1 Type 1 & Type 2 (Diabetes)9.5 Blood Glucose Device (SMBG) Users9.5.1 Type 1 & Type 2 (Diabetes)9.6 Reimbursement of Blood Glucose Devices in the Netherlands10. Insulin Pen Market & User Analysis10.1 Insulin Pen User10.1.1 Disposable Insulin Pen Users10.1.2 Reusable Insulin Pen Users10.1.3 Smart Insulin Pen Users10.2 Insulin Pen Market10.2.1 Disposable Insulin Pen Market10.2.2 Reusable Insulin Pen Market10.2.3 Smart Insulin Pen Market10.3 Insulin Pen Needle Market10.4 Reimbursement Policies11. Insulin Pump Market & Users & Forecast11.1 Insulin Pump Users & Forecast11.1.1 Type 1 & Type 2 (Insulin Pump User & Forecast)11.2 Insulin Pump Market & Forecast11.2.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)11.3 Differentiation Points of Insulin Pump Products in the United Kingdom11.3.1 Animas Vibe11.3.2 Medtronic 530G with Enlite11.3.3 Insulet OmniPod11.3.4 Tandem t: slim11.3.5 Roche Accu-Chek Combo11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care11.4.1 Medtronic11.5 Insulet Corporation11.5.1 Training Structure for New Patients - Insulet Corporation11.6 Animas Corporation11.6.1 Training Modules fo/r New Patients11.6.2 Training Modules for HCP (Health Care Professional)11.7 Tandem Diabetes Care11.8 Reimbursement Policies on Insulin Pump12. Insulin Pen - Company Analysis B. Braun Melsungen AG Eli Lilly and Company Artsana S.p.A BD Novo Nordisk A/S Owen Mumford Ltd Ypsomed AG Medtronic Insulet Corporation LifeScan Inc. Abbott Laboratories Roche Dexcom Inc For more information about this report visit https://www.researchandmarkets.com/r/mtm47c Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Netherlands Diabetes Market Report 2020: Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast to 2025